StockData
Ocugen, Inc. logo

Ocugen, Inc. (OCGN) stock

OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$0.83−0.05 (-5.24%)

Close on Nov 13, 2026Market cap $280.72MP/E –Yield –

Ocugen statistics

63 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 3, 2027 (estimated, during market hours)
Last ex-dividend date
Sep 30, 2019
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$280.72M
$272.32M
Enterprise Value
$198.19M
$146.23M

Share statisticsIndustry

Shares Change (QoQ)
0.08%
0.50%
Float
331M
49M
Shares Held by Insiders
2.41%
11.7%
Shares Held by Institutions
42.8%
56.4%

Short sellingIndustry

Short Interest
108M
–
Short Interest Change
0.48%
-0.80%
Short % of Float
32.5%
9.01%
Short % of Shares Outstanding
31.8%
6.30%
Days to Cover
16.40
5.15

Stock price statisticsIndustry

52-Week High
$2.73
–
52-Week Low
$0.69
–
20-Day Moving Average
$0.82
–
50-Day Moving Average
$0.94
–
200-Day Moving Average
$1.39
–
Average True Range (14)
$0.08
–
Price Change (1 Week)
-10.5%
-1.15%
Price Change (1 Month)
1.73%
-4.87%
Price Change (3 Months)
-39.8%
-21.0%
Price Change (6 Months)
-40.4%
-20.6%
Price Change (YTD)
-38.7%
-23.6%
Price Change (1 Year)
-38.2%
-22.4%
Price Change (3 Years)
121.3%
-29.5%
Price Change (5 Years)
-90.6%
-77.9%
Price Change (10 Years)
-99.4%
-65.4%
Average Volume (10 Days)
8M
–
Average Volume (20 Days)
7M
–
Average Volume (90 Days)
6M
–
Relative Volume
2.69
0.70
Relative Strength Index (14)
45.7
43.4
Volatility (1 Year)
82.6%
80.1%
Beta (5 Years)
1.65
1.07

Returns on capitalIndustry

Return on Assets (ROA)
-78.9%
-40.6%

Financial positionIndustry

Current Ratio
0.77
3.30
Quick Ratio
0.71
2.39
Interest Coverage
-6.76
-6.35

GrowthIndustry

Revenue Growth (3Y CAGR)
21.0%
2.25%
Revenue Growth (5Y CAGR)
152.5%
6.41%

EfficiencyIndustry

Profits Per Employee
-$563.43K
-$689.41K
Employee Count
116
74
WACC
13.4%
10.2%

Income statement (TTM)Industry

Operating Income
-$69.03M
-$21.37M
Net Income
-$65.36M
-$22.35M
EBITDA
-$69.03M
-$17.21M

Balance sheetIndustry

Total Debt
$1.78M
$116.91M
Net Cash (Debt)
$82.52M
$17.76M
Net Cash Per Share
$0.24
$0.80
Equity (Book Value)
-$17.68M
$53.89M
Book Value Per Share
-$0.05
$1.50
Tangible Book Value
-$17.68M
$27.13M
Working Capital
-$27.47M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$63.69M
-$12.38M
Capital Expenditures
-$211.00K
-$1.00M
Free Cash Flow
-$63.90M
-$18.21M
FCF Per Share
-$0.19
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-23.3%
-21.8%
FCF Yield
-22.8%
-9.44%

Taxes and interestIndustry

Interest Expense
$10.22M
$2.90M

Scores and fair valueIndustry

Altman Z-Score
-6.98
0.23
Piotroski F-Score
0
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodOCGNS&P 500DifferenceOCGN per yearS&P 500 per year
1 month-6.5%-3.0%−3.5 pts
3 months-38.7%-2.8%−35.9 pts
Year to date-38.7%+11.5%−50.2 pts
1 year-33.2%+13.5%−46.7 pts
3 years+126.8%+77.7%+49.1 pts+31.4%+21.1%
5 years-90.6%+72.6%−163.2 pts-37.7%+11.5%
10 years-99.3%+308.2%−407.5 pts-39.5%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

108M OCGN shares were sold short on Oct 30, 2026, up 0.5% from the previous report, or 32.54% of the shares available to trade. At recent volumes it would take 16.4 days to buy them back. Over the last 20 sessions, 64.7% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026107,672,000+0.5%6,564,94416.4
Oct 15, 2026107,157,106+5.0%6,787,96615.8
Sep 30, 2026102,053,118-3.8%7,472,50213.7
Sep 15, 2026106,062,298+7.9%10,210,18010.4
Aug 31, 202698,309,421-3.4%3,481,65928.2
Aug 14, 2026101,770,376+0.8%4,259,15523.9
Jul 31, 2026100,913,607+0.3%4,681,82121.6
Jul 15, 2026100,590,405-4.6%5,336,70318.9
Jun 30, 2026105,430,735+21.8%14,922,5907.1
Jun 15, 202686,561,503+4.3%4,682,76218.5
May 29, 202683,020,405+2.4%5,795,78614.3
May 15, 202681,047,338+16.3%9,926,2698.2

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?